CUREXO Inc. participated in the 69th Annual Congress of the Korean Orthopaedic Association (KOA 2025), held at COEX Magok from October 16 (Thu) to 18 (Sat), 2025.

During the congress, CUREXO showcased the CUVIS-joint (THA), which recently received approval from the Ministry of Food and Drug Safety (MFDS), and had meaningful interactions with domestic and international medical professionals and stakeholders.

CUVIS-joint (THA) is currently in the process of obtaining U.S. FDA and European CE certifications, as CUREXO continues to pursue global market expansion.